药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Ginkgo biloba
(R)-warfarin
The therapeutic efficacy of (R)-warfarin can be decreased when used in combination with Ubidecarenone.
Ginkgo biloba
Coumarin
The therapeutic efficacy of Coumarin can be decreased when used in combination with Ubidecarenone.
Ginkgo biloba
4-hydroxycoumarin
The therapeutic efficacy of 4-hydroxycoumarin can be decreased when used in combination with Ubidecarenone.
Ginkgo biloba
Clinafloxacin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Clinafloxacin.
Ginkgo biloba
Cibenzoline
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Cibenzoline.
Ginkgo biloba
Alaproclate
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Alaproclate.
Ginkgo biloba
Ritanserin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Ritanserin.
Ginkgo biloba
Indalpine
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Ubidecarenone.
Ginkgo biloba
Lanreotide
The risk or severity of hypoglycemia can be increased when Lanreotide is combined with Ubidecarenone.
Ginkgo biloba
Desvenlafaxine
The risk or severity of hypoglycemia can be increased when Desvenlafaxine is combined with Ubidecarenone.
Ginkgo biloba
Pasireotide
The risk or severity of hypoglycemia can be increased when Pasireotide is combined with Ubidecarenone.
Ginkgo biloba
Milnacipran
The risk or severity of hypoglycemia can be increased when Milnacipran is combined with Ubidecarenone.
Ginkgo biloba
Dapoxetine
The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Ubidecarenone.
Ginkgo biloba
Ertugliflozin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Ertugliflozin.
Ginkgo biloba
Liraglutide
The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Ubidecarenone.
Ginkgo biloba
Gastric inhibitory polypeptide
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Gastric inhibitory polypeptide.
Ginkgo biloba
Tirzepatide
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Tirzepatide.
Ginkgo biloba
Englitazone
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Englitazone.
Ginkgo biloba
Taspoglutide
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Taspoglutide.
Ginkgo biloba
Semaglutide
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Semaglutide.